Staphylococcus aureus nasal carriage among the diabetic and non-diabetic haemodialysis patients
- 8 September 2006
- journal article
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 60 (10) , 1204-1209
- https://doi.org/10.1111/j.1742-1241.2005.00789.x
Abstract
Staphylococcus aureus is the most common cause of serious infections in patients undergoing long-term haemodialysis (HD). S. aureus infections in HD patients are associated with considerable morbidity and mortality. Especially, methicillin-resistant S. aureus (MRSA) strains are becoming increasingly multidrug-resistant and have recently developed resistance to vancomycin, used successfully to treat MRSA for more than 30 years. In vitro determination of resistance patterns of S. aureus is critical in terms of administering suitable antimicrobial treatment. The objective of this study was to identify the frequency of S. aureus among diabetic and non-diabetic HD patients and to investigate resistance patterns against various antibiotics used broadly for treatment. This study was carried out between January 2004 and December 2004. In the present survey, 261 patients undergoing HD treatment from three HD units in Hatay were examined. A total of 148 Staphy-lococcus aureus strains were processed to assess their occurrence rates and antimicrobial susceptibility profiles. S. aureus positivity was determined in 148 (56.7%) of the 261 HD patients and 26 (16.2%) of the 160 individuals in the control group. The difference was significant (p < 0.001). HD length was found to be 38.4 ± 24.3 months in the patients of S. aureus carrier and 27.3 ± 18.5 months in non-carrier patients. Significant correlation was also identified between durations those on HD and the isolation of S. aureus (p < 0.001). However, the carrier state was unrelated to the presence of diabetes mellitus (DM), age or sex. In conclusion, nasal carriage of S. aureus was found to be more prevalent in HD patients than that in those in the control group. Also, it is concluded that DM was not a risk factor for the nasal carriage of S. aureus. In addition, the rates of antibiotic resistance of S. aureus strains were found to be quite higher in HD patients than in the control group (p < 0.05).Keywords
This publication has 24 references indexed in Scilit:
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2002
- The significance of nasal carriage ofStaphylococcus aureusas risk factor for human skin infectionsFEMS Microbiology Letters, 2001
- Staphylococcus aureus carriage and infections among patients in four haemo- and peritoneal-dialysis centres in DenmarkJournal of Hospital Infection, 1996
- Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: A decision analysisAmerican Journal of Kidney Diseases, 1996
- Neutrophil Bactericidal Function in Diabetes Mellitus: Evidence for Association with Blood Glucose ControlDiabetic Medicine, 1995
- The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infectionJournal of Hospital Infection, 1995
- The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: an analysis of cost-effectivenessJournal of Hospital Infection, 1991
- Staphylococcus aureus Colonization in Intravenous Drug Abusers, Dialysis Patients, and DiabeticsThe Journal of Infectious Diseases, 1987
- Staphylococcus aureusNasal Carriage and Infection in Patients on HemodialysisNew England Journal of Medicine, 1986
- Nasal and Cutaneous Staphylococcus among Patients Receiving Hemodialysis and Attending PersonnelThe Journal of Infectious Diseases, 1982